Thomas Lund

Using administrative sickness absence data as a marker of future disability pension: the prospective DREAM study of Danish private sector employees

Thomas Lund, Mika Kivimäki, Merete Labriola et al. · Occupational and Environmental Medicine · 2007 · 171 citations

Public Affairs, Geriatric Medicine, Disability +12

Coordinated and Tailored Work Rehabilitation: A Randomized Controlled Trial with Economic Evaluation Undertaken with Workers on Sick Leave Due to Musculoskeletal Disorders

Ute Bültmann, David Sherson, Jens Olsen et al. · Journal of Occupational Rehabilitation · 2009 · 152 citations · Full text

Health Professions, Health Sciences, Rehabilitation Medicine +17

Multiple myeloma–derived MMP-13 mediates osteoclast fusogenesis and osteolytic disease

Jing Fu, Shirong Li, Rentian Feng et al. · Journal of Clinical Investigation · 2016 · 74 citations · Full text

Medicine, Cell Biology, Apoptosis +16

Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resorptive activity in clinically relevant conditions

Patrice Boissy, Thomas Levin Andersen, Thomas Lund et al. · Leukemia Research · 2008 · 59 citations

Medicine, Oncology, Apoptosis +16

A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma

P K. Pedersen, TL Andersen, Kent Søe et al. · Hematological Oncology · 2008 · 58 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17